Drug Detail
Information about Belinostat
Generic Name |
Belinostat | |
|---|---|---|
IND |
PXD101 | |
Brand Name (US) |
||
Manufacturer |
Topo/Target A/S | |
Drug Type |
HDAC Inhibitor | |
Delivery |
Intravenous | |
Approval Status |
Phase 2 | |
Indications |
||
Overall Strategy |
GIST cell based | |
Strategy |
Unblock cell death genes | |
Drug Category |
HDAC inhibitor | |
Links |
|
|
Topotarget's webpage about belinostat |
Trials of this drug |
|
|
Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma |
Trial results |
|
Search for this drug/combination in: